UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 28, 2026
Sale
Calculated transaction value
$361.43K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 27, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$527.91
Aug 27, 2026
Close before public filing
$527.91
Aug 27, 2026
Return since public filing
-5.83%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 704 shares @ $513.4
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000130
Filing cohort
Transactions in this filing
Showing 15 of 20
Trades
20
Issuers
1
Estimated value
$6.25M
Buys / sales
0 / 18
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 27, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $252.72K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $329.01K |
| United Therapeutics Corp UTHR Current | Sale | Aug 27, 2026 | $361.43K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $61.72K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $123.68K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $144.78K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $103.78K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $521.79K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $248.63K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $146.27K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $125.66K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $390.31K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $197.63K |
| United Therapeutics Corp UTHR | Sale | Aug 27, 2026 | $147.38K |